GENEVA, Oct. 15 -- ARGENX BV filed a patent application (EP2026/060358) for “METHODS OF TREATING CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING LIQUID FORMULATIONS OF FCRN ANTAGONISTS”. With publication no. WO/2026/215434, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 25/02
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....